Insuring patient access and affordability for treatments for rare and ultrarare diseases: a policy statement of the American College of Medical Genetics and Genomics
Crossref DOI link: https://doi.org/10.1038/s41436-018-0059-8
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2018-11-01
Version of Record valid from 2022-01-19
Article History
Received: 2 May 2018
Accepted: 2 May 2018
First Online: 22 August 2018
DISCLOSURE
: The authors declare no conflict of interest.